| MPS Pharmaa Ltd | 7.99 Cr. | 4.18 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,053 Cr. | 280 | 390/210 | 57.9 | 20.5 | 0.24 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 58.2 Cr. | 78.4 | 94.9/27.0 | 19.7 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 37.4 Cr. | 25.6 | 28.0/8.74 | 38.2 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 77.4 Cr. | 103 | 155/87.0 | 11.6 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 317 Cr. | 14.0 | 29.0/13.1 | 18.4 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 344 Cr. | 733 | 1,054/635 | 19.5 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 72.3 Cr. | 24.1 | 32.0/14.6 | | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,149 Cr. | 390 | 440/145 | 140 | 98.6 | 0.32 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 5.75 Cr. | 27.4 | 43.8/23.6 | 115 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 16.8 Cr. | 6.75 | 15.4/6.72 | 37.4 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 255 Cr. | 263 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
| Entero Healthcare Solutions Ltd | 6,635 Cr. | 1,525 | 1,584/970 | 92.9 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
| Murae Organisor Ltd | 166 Cr. | 1.79 | 3.03/1.03 | 35.3 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 37.9 Cr. | 15.8 | 16.4/6.40 | 45.7 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 14.3 Cr. | 14.1 | 24.6/13.5 | 17.2 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 275 Cr. | 769 | 999/345 | 11.8 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 33.2 Cr. | 33.2 | 49.0/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
| Colinz Laboratories Ltd | 26.1 Cr. | 57.0 | 84.4/36.0 | 53.2 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 8.02 Cr. | 3.21 | 26.5/2.97 | 32.1 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.4 Cr. | 76.3 | 154/52.2 | 28.6 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 5.48 Cr. | 10.0 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 47.5 Cr. | 63.0 | 148/60.0 | 30.1 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 5.18 Cr. | 17.3 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
| Blue Jet Healthcare Ltd | 13,959 Cr. | 805 | 805/324 | 59.5 | 53.3 | 0.12 % | 30.0 % | 22.4 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 111 Cr. | 25.7 | 42.0/22.2 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 17.2 Cr. | 34.0 | 46.0/26.0 | 50.7 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 184 Cr. | 319 | 418/240 | 18.9 | 110 | 1.41 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 25.6 Cr. | 43.5 | 62.6/7.58 | 73.2 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 68,537 Cr. | 1,171 | 1,593/958 | 18.8 | 527 | 0.38 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 146 Cr. | 234 | 307/137 | 23.6 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 989 Cr. | 198 | 265/165 | 16.8 | 60.5 | 1.26 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 52.5 Cr. | 40.2 | 70.0/37.2 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
| Ami Organics Ltd | 10,617 Cr. | 2,596 | 2,615/1,004 | 87.3 | 294 | 0.12 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.48 Cr. | 0.98 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 378 Cr. | 49.3 | 77.7/39.2 | 28.4 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 28.7/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 102 Cr. | 4.35 | 6.25/2.87 | 155 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 55,456 Cr. | 26,123 | 30,683/25,200 | 43.2 | 1,657 | 1.57 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,648 Cr. | 623 | 722/381 | 24.8 | 205 | 0.48 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 128 Cr. | 47.1 | 75.8/37.0 | 18.5 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,783 Cr. | 1,015 | 1,060/440 | | 58.0 | 0.10 % | 7.32 % | 16.8 % | 10.0 |
| Wockhardt Ltd | 26,496 Cr. | 1,630 | 1,644/420 | | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
| Wanbury Ltd | 707 Cr. | 216 | 325/122 | 25.6 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
| Venus Remedies Ltd | 390 Cr. | 293 | 428/270 | 17.7 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,060 Cr. | 717 | 950/433 | 101 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 1,806 Cr. | 1,263 | 1,923/1,241 | 26.4 | 735 | 0.79 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,05,038 Cr. | 3,103 | 3,591/2,488 | 56.4 | 222 | 0.90 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,052 Cr. | 223 | 317/181 | 38.7 | 44.8 | 0.22 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,693 Cr. | 18.0 | 27.9/11.0 | 53.3 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 28,888 Cr. | 1,134 | 1,360/585 | 119 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,852 Cr. | 131 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,23,701 Cr. | 1,765 | 1,960/1,377 | 35.9 | 288 | 0.76 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,256 Cr. | 532 | 886/322 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
| SMS Pharmaceuticals Ltd | 1,739 Cr. | 206 | 398/122 | 29.6 | 70.6 | 0.19 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 381 Cr. | 1,232 | 1,750/538 | 18.8 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,114 Cr. | 729 | 960/358 | 124 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,103 Cr. | 164 | 241/91.8 | 193 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 12,566 Cr. | 5,457 | 7,600/4,606 | 29.8 | 298 | 3.06 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 4,216 Cr. | 2,553 | 2,977/1,360 | 44.1 | 229 | 0.63 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,805 Cr. | 5,302 | 5,850/4,637 | 38.8 | 324 | 1.13 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 250 Cr. | 70.9 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
| Pfizer Ltd | 20,221 Cr. | 4,426 | 6,453/3,950 | 32.8 | 820 | 0.79 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 238 Cr. | 194 | 348/180 | 13.0 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,290 Cr. | 372 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 7,278 Cr. | 1,437 | 1,998/813 | 61.2 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 18,748 Cr. | 14,623 | 18,100/5,532 | 71.0 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 800 Cr. | 35.5 | 56.5/26.2 | 47.0 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 22,121 Cr. | 1,235 | 1,639/828 | 11.4 | 399 | 0.77 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 3,514 Cr. | 64.1 | 101/38.6 | 26.8 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 11,098 Cr. | 245 | 359/126 | 32.1 | 50.3 | 0.24 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 172 Cr. | 108 | 145/85.2 | 18.2 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 520 Cr. | 146 | 177/97.9 | 127 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 96,301 Cr. | 2,111 | 2,403/1,493 | 36.7 | 343 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,391 Cr. | 694 | 980/498 | 14.4 | 319 | 0.26 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 32,980 Cr. | 612 | 620/372 | 132 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 821 Cr. | 791 | 1,070/405 | 23.3 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 225 Cr. | 103 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
| Kopran Ltd | 852 Cr. | 178 | 370/174 | 16.1 | 103 | 1.68 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 511 Cr. | 317 | 470/298 | 36.3 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 15,252 Cr. | 956 | 1,310/538 | 45.8 | 373 | 0.52 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,145 Cr. | 1,742 | 2,030/1,474 | 42.4 | 207 | 0.70 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,715 Cr. | 259 | 328/108 | 47.1 | 29.7 | 0.77 % | 17.0 % | 13.0 % | 2.00 |
| Ipca Laboratories Ltd | 37,272 Cr. | 1,468 | 1,758/1,052 | 59.8 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,154 Cr. | 368 | 538/331 | 21.5 | 283 | 1.36 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 93.4 Cr. | 17.3 | 34.7/14.3 | 1.70 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 610 Cr. | 103 | 186/86.2 | 5.98 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 2,436 Cr. | 264 | 388/242 | | 118 | 0.57 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,319 Cr. | 350 | 465/260 | 58.0 | 97.6 | 0.34 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 1,619 Cr. | 1,904 | 3,379/1,293 | 52.4 | 355 | 0.32 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,238 Cr. | 426 | 504/278 | 49.9 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 13,836 Cr. | 571 | 725/382 | 28.9 | 141 | 0.26 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 40,996 Cr. | 1,452 | 1,831/767 | | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 33,175 Cr. | 1,960 | 3,088/1,825 | 41.4 | 98.7 | 1.63 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 23,931 Cr. | 1,459 | 2,221/1,414 | 21.3 | 557 | 1.37 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 7,766 Cr. | 476 | 659/405 | 24.5 | 141 | 1.05 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 16,793 Cr. | 1,232 | 1,594/809 | 51.0 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,01,783 Cr. | 1,220 | 1,421/1,120 | 19.0 | 369 | 0.66 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,831 Cr. | 245 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
| Cipla Ltd | 1,16,998 Cr. | 1,449 | 1,702/1,317 | 23.5 | 351 | 0.90 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 16,022 Cr. | 2,107 | 2,641/1,221 | 32.5 | 334 | 0.24 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 415 Cr. | 157 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,470 Cr. | 140 | 186/92.2 | 17.4 | 95.8 | 0.36 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 89.1 Cr. | 54.9 | 92.0/49.0 | 168 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 44,603 Cr. | 371 | 405/244 | 54.2 | 175 | 0.13 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,933 Cr. | 2,010 | 2,326/1,060 | 47.1 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 174 Cr. | 111 | 158/89.0 | 22.9 | 43.2 | 1.08 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 187 Cr. | 80.8 | 113/73.2 | 243 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 18,642 Cr. | 7,485 | 8,140/4,050 | 145 | 272 | 0.32 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,897 Cr. | 656 | 863/571 | 39.9 | 103 | 0.70 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 241 Cr. | 115 | 145/69.9 | 11.6 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 61,105 Cr. | 5,106 | 6,440/4,407 | 28.1 | 961 | 0.78 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,297 Cr. | 881 | 1,304/823 | 29.1 | 249 | 1.25 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 669 Cr. | 1,163 | 1,754/1,010 | 9.75 | 724 | 0.99 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 34,888 Cr. | 2,798 | 3,486/1,998 | 38.9 | 294 | 1.29 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,750 Cr. | 335 | 571/312 | 25.6 | 120 | 1.52 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 3,800 Cr. | 414 | 635/387 | 28.8 | 126 | 0.24 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 14,120.08 | N/A | | 39.72 | N/A | N/A | 16.05 | 15.89 | N/A |
